Document is current
Any future updates will be listed below
-
Authors
Wang, Di https://orcid.org/0000-0002-8904-2981
Lü, Jia-Qi https://orcid.org/0000-0003-2171-5139
Kuang, Xiao https://orcid.org/0000-0001-6596-1417
Lian, Liming
Yi, Sili
Ravanbakhsh, Hossein
Li, Jin-Song
Tang, Guosheng
Xie, Maobin https://orcid.org/0000-0001-9082-4510
Garciamendez-Mijares, Carlos Ezio
Agrawal, Prajwal
Wang, Zixuan
Maharjan, Sushila https://orcid.org/0000-0003-3957-3976
Chen, Wen
Jiang, Haiyue https://orcid.org/0009-0003-5838-4828
Zhang, Yu Shrike https://orcid.org/0000-0002-0045-0808
-
Funding
Funding for this research was provided by:
BWH | Brigham Research Institute
National Research Foundation of Korea
- License Information
-
More Information
Article History
Received: 26 January 2024
Accepted: 13 April 2026
First Online: 1 June 2026
Competing interests
: Y.S.Z. consulted for Allevi by 3D Systems; consults for PepGel; cofounded, consults for and holds options of Linton Lifesciences and Criocore; and sits on the scientific advisory board and holds options of Xellar Biosystems. The relevant interests are managed by the Brigham and Women’s Hospital. The other authors declare no competing interests.
